Search

Your search keyword '"Pipitone N"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Pipitone N" Remove constraint Author: "Pipitone N" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
30 results on '"Pipitone N"'

Search Results

1. Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study

2. OP0014 TRANSCRIPTS EXPRESSED IN TEMPORAL ARTERY BIOPSIES ASSOCIATED WITH RESPONSE TO THERAPY IN PATIENTS WITH GIANT CELL ARTERITIS

3. POS0115 EOSINOPHILIC GIANT CELL ARTERITIS: A DIFFERENT SUBSET OF DISEASE?

4. OP0025 GENOME-WIDE DNA METHYLATION STUDY REVEALS SPECIFIC SIGNATURES IN THE AFFECTED ARTERIAL TISSUE OF GIANT CELL ARTERITIS PATIENTS

6. POS0728 EFFECTIVENESS AND SAFETY OF A 26 WEEK TAPER REGIMEN OF GLUCOCORTICOID IN NEWLY-DIAGNOSED GCA PATIENTS: A REAL LIFE EXPERIENCE

7. POS1221 CLINICAL FEATURES OF PATIENTS WITH ANTI-SYNTHETASE SYNDROME AND DERMATOMYOSITIS-ASSOCIATED SKIN MANIFESTATIONS: RESULTS FROM THE MYONET REGISTRY

8. Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies

9. CLINICAL FEATURES OF PATIENTS WITH ANTI-SYNTHETASE SYNDROME AND DERMATOMYOSITIS-ASSOCIATED SKIN MANIFESTATIONS: RESULTS FROM THE MYONET REGISTRY.

11. Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies

12. Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.

13. Interstitial lung disease in rheumatic diseases: an update of the 2018 review.

14. Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.

15. Eosinophilic giant cell arteritis: A different subset of disease?

16. Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study.

17. Steroid-sparing agents in polymyalgia rheumatica: how will they fit into the treatment paradigm?

18. The role of PET/CT in disease activity assessment in patients with large vessel vasculitis.

19. Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis.

20. Rare forms of inflammatory myopathies - part I, generalized forms.

21. Rare forms of inflammatory myopathies - part II, localized forms.

22. Comparing treatment options for large vessel vasculitis.

23. Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment.

24. A glance into the future of myositis therapy.

25. Clinical Relevance of Subcentimetric Lymph Node Biopsy in the Diagnosis of Ocular Sarcoidosis.

26. VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis.

27. Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet's Uveitis: Customizing Therapy according to the Clinical Features.

28. Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies.

29. Clinical Features and Prevalence of Spondyloarthritis in a Cohort of Italian Patients Presenting with Acute Nongranulomatous Anterior Uveitis.

Catalog

Books, media, physical & digital resources